Skip to content

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04262713
Acronym
MEIJE
Enrollment
256
Registered
2020-02-10
Start date
2019-03-23
Completion date
2022-04-11
Last updated
2023-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthropathy Associated With Other Conditions

Brief summary

A normative development concerning the mechanical resistance tests of the the femoral stems led to contraindicate, in September 2014, to implant Meije Duo ™ femoral stems size 1 or 2 in patients weighing more than 60 kg due to an assumed risk of femoral stem breakage. This contraindication is based on standardized mechanical tests which may have not taken into account the changes in patient weight that may occur after the intervention. To date, investigators have not been aware of any Meije Duo ™ size 1/2 brakeage in our patients implanted with this type of prosthesis regardless of their weights before 2014. However, it is possible that some of them have had a prostheses failure and consulted another hospital. In the absence of a clinical study on this problem, investigators decided to set up a health care assessment study collecting retrospective and prospective information from our patients.

Detailed description

First, patients with Meije Duo ™sizes 1 or 2, who had surgery from 2007 to 2014, will be preselected on medical records. The information notice will be sent to them by post. A period of reflection will be respected before contacting the patient to answer their questions concerning the research and its progress and obtain their oral consent to participate in the study. After obtaining consent, investigators will enter the retrospective data collected in the medical and prospective file collected during this call. Patients with at least one of the following criteria: weight\> 60 kg and / or long neck / varus and / or DEVANE score ≥ 4, will be selected to have a hip X-ray which will be specially scheduled for the study. This examination will tell us about the state of the prosthesis and of the underlying bone (broken stem, loosening of the implant, bone fracture, dislocation, border, etc. It can be performed in our radiology department of the Diaconesses Croix Saint Simon hospital group or in another radiological center chosen by the patient if the latter cannot come to our hospital. In this case, a prescription for a hip X-ray will be sent to him by post to his current address as well as an information letter intended for the radiology office. The patients who will be included in the study are implanted with Meije Duo ™ 1 and 2 between 2007 to 2014 and will all have a minimum follow-up of 4 years from the date of implantation. The maximum number of rupture complications is observed between the fourth and the eleventh year after fitting the prosthesis. All participants will therefore have a minimum of hindsight required for the evaluation of stem breaks. All of our patients will be contacted by telephone during the study period in chronological order of their previous management for obtaining consent, prospective data and for scheduling the hip radiography according to the criteria mentioned above.

Interventions

Radiographs of the implanted hip with Meije duo size1 or 2 are performed in eligible patients ( Weigh\>60, Long neck stem, Varus; DEVANE score ≥ 4)

Sponsors

Groupe Hospitalier Diaconesses Croix Saint-Simon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

An x-ray of the hip concerned will be performed on all consenting patients, having at least one criterion of the following three during their medical history since the implantation of the hip prosthesis. * Weight\> 60 kg * DEVANE score ≥ 4 * Long neck / varus

Exclusion criteria

* The patient expresses his opposition to the use of his personal data * Patients (\<18 years old) * Patients unable or out of state to express their consent * Patient unable to speak French * Patient with memory impairment or cognitive impairment * Patient not affiliated to a social security or equivalent health coverage

Design outcomes

Primary

MeasureTime frameDescription
Pourcentage of participants who had stem (Meije DuoTM size 1 or 2) breakage occured between implantation and the study follow-up call phone.Up to 4 weeks, starting from the call phone (patient consent)The number of stem breakage that occured since prostheses implantation will be collected by asking every participant during the follow-up call phone and performing hip xray to eligible ones (see above)

Secondary

MeasureTime frameDescription
Pourcentage of participants who had other prostheses failures (loosening of the prosthesis, femoral fracture, dislocation)Up to 4 weeks, starting from the call phone (patient consent)The number of prostheses failures that occured since the implantation will be collected by asking every participant during the follow-up call phone and by performing hip xray to eligible ones (see above)
The change of physical activity in participants from baseline (prostheses implantation) to study call-phone point time.Change from baseline Devane score at postoperative 4 yearsWith DEVANE questionnaire, investigator will assess physical activity of participants
The change of the weight and the body mass index (BMI) of the patients after the implantation of Meije DuoTM rods size 1 or 2Change from baseline weight and BMI at postoperative 4 yearsPreoperative weight and BMI of particpantS will be collected from the medical file and postopeartive weight and BMI during follow up call phone

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026